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OBJECTIVES: Conflicting results were reported about the effectiveness of Low level laser therapy on musculoskeletal
disorders. The aim of this study was to investigate the effectiveness of 850-nm gallium arsenide aluminum (Ga-As-Al)
laser therapy on pain, range of motion and disability in subacromial impingement syndrome.
METHODS: A total of 52 patients (33 females and 19 males with a mean age of 53.59¡11.34 years) with subacromial
impingement syndrome were included. The patients were randomly assigned into two groups. Group I (n=30, laser
group) received laser therapy (5 joule/cm
2 at each point over maximum 5-6 painful points for 1 minute). Group II
(n=22, placebo laser group) received placebo laser therapy. Initially cold pack (10 minutes) was applied to all of the
patients. Also patients were given an exercise program including range of motion, stretching and progressive
resistive exercises. The therapy program was applied 5 times a week for 14 sessions. Pain severity was assessed by
using visual analogue scale. Range of motion was measured by goniometer. Disability was evaluated by using
Shoulder Pain and Disability Index.
RESULTS: In group I, statistically significant improvements in pain severity, range of motion except internal and
external rotation and SPADI scores were observed compared to baseline scores after the therapy (p,0.05). In Group
II, all parameters except range of motion of external rotation were improved (p,0.05). However, no significant
differences were recorded between the groups (p.0.05).
CONCLUSIONS: The Low level laser therapy seems to have no superiority over placebo laser therapy in reducing pain
severity, range of motion and functional disability.
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INTRODUCTION
Shoulder pain is one of the major symptoms of upper
extremity.
1 The most frequent cause of shoulder pain is
subacromial impingement syndrome (SAIS).
2 It is associated
with repetitive overuse and caused by compression of
supraspinatus tendon between humerus and coracoacro-
mial arc during elevation of arm or overhead activities. This
painful condition leads decreases in muscle strength and
range of motion (ROM) of the shoulder which adversely
affect the patients’ quality of life.
3
The SAIS causes edema, inflammation and can become
chronic if adequate treatment isn’t applied. Conservative
and surgical treatment approaches can be used to reduce
pain, improve joint stiffness, impaired muscle strength and
quality of life in patients with SAIS. The conservative treat-
ment methods include analgesic and nonsteroidal antiin-
flammatory drugs, resting, modification of daily activities,
physical therapy approaches, range of motion and strength-
ening exercises, subacromial local anesthetic or corticoster-
oid injections.
4-6
Laser is a noninvasive, nonionising, monochromatic
electromagnetic high concentrated light beam. Recently,
low level laser therapy (LLLT) is widely used in various
rheumatologic and musculoskeletal disorders which have
analgesic, anti-inflammatory and biostimulating effects. The
LLLT induces cell proliferation, collagen synthesis, protein
synthesis, tissue reparation, wound healing and pain relief
through direct irradiation without thermal response.
7-12
However, conflicting results were reported about its
effectiveness on musculoskeletal disorders. Some of the
randomized controlled studies suggest that LLLT may be
effective in pain relief in different musculoskeletal dis-
orders.
13,14 On the other hand some of them have failed to
show any superiority over placebo.
9,15-17
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1019Limited number of studies were investigated the effec-
tiveness of LLLT in shoulder disorders.
13,17-20 One of them
was reported no beneficial effect when combined with
exercise.
20 When compared to placebo, no differences were
detected in two studies.
17,18 The aim of this study was to
investigate the effectiveness of 850-nm gallium arsenide
aluminum (Ga-As-Al) laser therapy on pain, range of
motion (ROM) of shoulder joint and disability in subacro-
mial impingement syndrome (SAIS).
MATERIALS AND METHODS
Patients
A total of 52 patients (33 females, 19 males) with a mean
age of 53.59¡11.34 years with SAIS were included in the
study. The diagnoses of SAIS were made according to
detailed physical and neurologic examination. After physi-
cal examination magnetic resonance imaging (MRI) were
done to exclude rotator cuff tears. Complete blood count,
biochemical markers, erythrocyte sedimentation rate and C-
reactive protein were also evaluated. The exclusion criterias
were; presence of acute trauma, acromioclavicular arthritis,
glenohumeral arthritis, tears of rotator cuff, neurologic or
inflammatory diseases, referring pain due to neck pathol-
ogies and history of physical therapy, surgery, subacromial
or intraarticular injection within 6 months.
Treatment groups
The patients were randomly assigned into two groups.
Randomization was allocated by numbered envelopes
method. Treatment program either LLLT or placebo was
written in these closed envelopes and patients selected one
of them and randomly assigned into two groups.
Group I (n=30, laser group) received cold pack therapy,
LLL therapy (3 joule/cm
2 at each point over maximum 5-6
painful points for 1 minute) and exercise program.
Group II (n=22, placebo laser group) received cold pack
therapy, placebo laser therapy and exercise program.
The placebo laser group consisted in patients who were
sex- and age-matched to the patients in laser group.
The Gallium-Aluminum-Arsenide (GaAlAs, infrared laser)
diode laser device (Chattanooga group, USA) with a wave-
length of 850nm, power output of 100mV, continuous wave
and 0.07cm
2 spot area laser were used for the laser therapy.
The laser was applied with a dosage of 5 joule/cm
2 (totally 15-
20 joule) at maximum 5-6 painful points for 1 minute at each
point over subacromial region of the shoulder.
Placebo laser was applied in the same way but the device
was turned off during treatment sessions. Patients and
physiotherapist were asked to use protective eyeglasses
during therapy for safety.
Cold pack therapy during 10 minutes was applied to all
patients in both groups.
Also patients were given an exercise program which
included range of motion, stretching and progressive
resistive exercises. Each exercise was performed once a
day with 10-15 repetitions. The therapy program was
applied 5 times a week, once a day for 14 sessions.
Outcome measures
At the beginning, sociodemographic (age, sex) and clinic
(disease duration, localization of shoulder pain) character-
istics of the patients were recorded. Pain severity, range of
motion and functional status of all patients were evaluated
before and after the treatment by different physicians. Both
of the physicians and patients were blinded. Only the
physiotherapist was aware of the procedure.
Pain severity was assessed by visual analogue scale (VAS,
0-10cm; 0 means no pain, 10 means severe pain).
Range of motion including flexion, abduction, adduction,
internal and external rotation was measured by using
goniometer in supin position. Extension was measured in
prone position.
Functional status was evaluated by using Shoulder Pain
and Disability Index (SPADI). This is a self-administered
shoulder specific questionnaire including two subscales;
pain and disability. Pain subscale consists of 5 items and
disability subscale consists of 8 items. Patients were asked to
answer each items using 0-100 mm VAS. The possible score
of SPADI was ranged from 0 to 100. Higher scores indicate
high level of disability.
21 The Turkish version of SPADI was
found to be reliable and valid by Bumin et al.
22
Signed written informed consent was obtained from all
patients. The Human Research Ethics Committee at School
of Medicine of Ufuk University approved the study.
Statistical analysis
All the data were analyzed using SPSS-16.0 statistical
package for Windows. The mean values and frequencies of
the parameters were assessed by descriptive statistics.
Mann-Whitney U test was used for comparing groups.
The differences before and after treatment for each group
were assessed by Wilcoxon test. And p,0.05 was accepted
to be statistically significance level.
RESULTS
Fifty two patients (33 females, 19 males) with a mean age
of 53.59¡11.34 years with SAIS were included in the study.
All patients were able to complete the therapy program
without any adverse effects. The results of complete blood
count, biochemical markers, erythrocyte sedimentation rate
and C-reactive protein of the patients were found to be
normal.
The sociodemographic and clinic characteristics of the
patients were given in Table 1. No statistically significant
differences were detected between the groups in initial
values (p.0.05).
In group I, after the therapy statistically significant
improvements in pain severity, ROM except internal and
external rotation and SPADI scores were observed com-
pared to baseline scores (p,0.05).
In Group II, all parameters except ROM of external
rotation were improved (p,0.05). However, no significant
differences were recorded between the groups (p.0.05)
(Table 2).
DISCUSSION
The results of this study indicated that both LLLT and
placebo LLLT combined with cold pack and exercise
program showed significant improvements in pain severity,
ROM measurements and functional status.
The LLLT has become popular in the treatment of
musculoskeletal disorders in recent years. The mechanism
of analgesic effect of LLLT is not well known. The increased
peripheral b-endorphin precursor mRNA expression in
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1020blood cells of the rats by 830 nm Ga-Al-Ar Laser irradiation
was demonstrated.
23 The analgesic mechanisms of LLLT in
rheumatoid arthritis were associated with reduced proin-
flammatory cytokines such as TNF-alpha, IL-1 beta, IL-8.
24
Decreased mitochondrial membrane potential, blockage of
axonal flow in dorsal root ganglion neurons of rats were
emphasized.
25 Some authors explained the analgesic effect
of laser therapy by altering sensorial input to the central
nervous system leading the decrease of pain perception.
16,26
Moreover, reduced prostaglandin concentrations with LLLT
were reported.
27,28 The stimulation of deposition of collagen
fibers can be related to the biostimulating effect of LLLT.
29
Since the anti-inflammatory, biostimulating, anti-edema-
tous and analgesic effects of laser therapy were demon-
strated.
23-25,27-29 It is thought to be beneficial in the treatment of
SAIS. England et al. compared the effectiveness of laser,
placebo laser therapy and naproxen sodium in patients with
supraspinatus or bicipital tendonitis. After 2 weeks of treat-
ment, they found improvement in laser therapy group
compared to placebo laser or naproxen sodium treatment
groups.
13 Bingol et al. investigated the efficacy of LLLT in
shoulder pain. Patients received laser and placebo laser
therapy combined with exercise protocol of 10 sessions for
2 weeks. Laser therapy was found to be superior over placebo
in palpation sensitivity and passive extension but no signifi-
cant differences were shown in pain severity, active ROM and
algometric sensitivity between the groups.
18 Stergioulas
applied LLLT and placebo laser for 12 sessions during 8 week
in patients with frozen shoulder and concluded that LLLT was
more effective in pain relief, disability than placebo.
19
Our results failed to demonstrate the superiority of LLLT
over placebo. Both groups showed improvements in pain
severity, ROM measurements and functional status.
Improvements in both groups may be due to additional
coldpack application and exercise program. It is known that
superficial cold induces vasoconstriction and reduces local
blood flow leading to decrease tissue swelling, inflamma-
tion and pain severity.
30 Nevertheless, the efficacy of
therapeutic exercise programs on pain reduction and
functional improvement in the treatment of SAIS was well
defined.
31,32 Similar to our findings, Yeldan et al., also found
improvements with both LLLT and placebo LLLT combined
with superficial cold and exercise program in pain severity,
functional status and muscle strength in patients with
SAIS.
17 In another study, the authors compared the
effectiveness of laser therapy combined with home exercise
program and home exercise program alone. They indicated
no additional effect of laser therapy over exercise alone.
20
There are several limitations of this study. First of all was
the small sample size. Another limitation was not to have an
only placebo LLLT group because of ethical reasons and
therefore coldpack and exercise program were associated to
LLLT. Finally, the assessment parameters were measured
after the therapy and long term results of the therapy were
not evaluated.
CONCLUSIONS
Finally there are controversial results about the efficacy
of laser therapy on shoulder pain. Our results showed
improvements on pain severity, ROM and functional status
of the patients with SAIS with the therapy program of laser
therapy, coldpack and exercise. However no superiority
over placebo laser therapy was observed. Further studies
Table 1 - The sociodemographic and clinic characteristic
of the patients.
Group I (n, %) Group II (n, %) p
Age , year (mean¡SD) 53.7¡12.6 53.45¡9.64 0.933
Gender
Female 20 (%66.7) 13(%59.1)
Male 10 (%33.3) 9(%40.9) 0.579
Disease duration, month
(mean¡SD)
11.66¡18.04 15.27¡25.13 0.237
Localization
Right 17 (%56.7) 12(%54.5)
Left 13 (%43.3) 10(%45.5) 0.880
VAS 7.16¡1.64 7.59¡1.76 0.343
VAS: Visual analog scale; SD: Standard deviation.
**p,0.01
*p,0.05
Table 2 - Comparison of mean values of pain severity,
ROM and SPADI scores before and after the treatment
between the groups.
Group I Group II p
VAS
Baseline (mean¡SD) 7.16¡1.64 7.59¡1.76 0.343
Posttreatment (mean¡SD) 3.76¡1.45 4.63¡2.10 0.216
p 0.000** 0.000**
Shoulder flexion
Baseline (mean¡SD) 156¡30.77 167.50¡21.14 0.284
Posttreatment (mean¡SD) 168¡22.65 174.31¡14.98 0.313
p 0.001** 0.011*
Shoulder extension
Baseline (mean¡SD) 38.16¡13.42 39.31¡8.20 0.372
Posttreatment (mean¡SD) 42.66¡3.40 42.95¡3.98 0.457
p 0.007** 0.006**
Shoulder abduction
Baseline (mean¡SD) 147.16¡33.52 160.68¡30.71 0.145
Posttreatment (mean¡SD) 166.66¡21.38 172.72¡16.67 0.140
p 0.001* 0.007**
Shoulder adduction
Baseline (mean¡SD) 38.50¡15.98 38.40¡7.92 0.438
Posttreatment (mean¡SD) 42.00¡4.27 42.04¡5.26 0.556
p 0.003** 0.008**
Shoulder internal rotation
Baseline (mean¡SD) 47.50¡9.89 47.95¡5.26 0.718
Posttreatment (mean¡SD) 49.33¡9.62 49.77¡4.49 0.344
p 0.439 0.039*
Shoulder external rotation
Baseline (mean¡SD) 44.16¡10.09 44.77¡8.23 0.752
Posttreatment (mean¡SD) 44.83¡5.64 44.09¡1.97 0.517
p 0.205 0.480
SPADIpain
Baseline (mean¡SD) 70.66¡24.37 70.09¡16.76 0.330
Posttreatment (mean¡SD) 48.13¡22.10 40.99¡20.98 0.211
p 0.000** 0.000**
SPADIdisability
Baseline (mean¡SD) 58.12¡24.36 55.17¡19.02 0.282
Posttreatment (mean¡SD) 40.54¡21.40 31.87¡21.08 0.115
p 0.000** 0.000**
SPADItotal
Baseline (mean¡SD) 64.39¡23.65 62.63¡16.58 0.236
Posttreatment (mean¡SD) 44.33¡2.80 36.39¡20.53 0.201
p 0.000** 0.000**
VAS: Visual analog scale; SPADI: Shoulder pain and disability index; SD:
Standard deviation.
**p,0.01
*p,0.05
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1021with large samples, longer follow up durations were
required to demonstrate its efficacy, optimum dosage, type,
frequency and duration.
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